BIT
SGYP

BlackRock Institutional Trust’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

BlackRock Institutional Trust’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$30.6M Buy
5,026,056
+535,118
+12% +$2.8M ﹤0.01% 1654
2016
Q3 		$24.7M Buy
4,490,938
+804,382
+22% +$3.77M ﹤0.01% 1733
2016
Q2 		$14M Buy
3,686,556
+1,093,237
+42% +$3.71M ﹤0.01% 2075
2016
Q1 		$7.16M Buy
2,593,319
+8,835
+0.3% +$32K ﹤0.01% 2477
2015
Q4 		$14.7M Buy
2,584,484
+90,408
+4% +$551K ﹤0.01% 2072
2015
Q3 		$13.2M Buy
2,494,076
+482,415
+24% +$3.73M ﹤0.01% 2108
2015
Q2 		$16.7M Buy
2,011,661
+45,126
+2% +$219K ﹤0.01% 2043
2015
Q1 		$9.09M Buy
1,966,535
+713,752
+57% +$2.32M ﹤0.01% 2448
2014
Q4 		$3.82M Buy
1,252,783
+131,452
+12% +$389K ﹤0.01% 2829
2014
Q3 		$3.12M Sell
1,121,331
-24,943
-2% -$90.5K ﹤0.01% 2880
2014
Q2 		$4.67M Buy
1,146,274
+118,029
+11% +$501K ﹤0.01% 2813
2014
Q1 		$5.46M Sell
1,028,245
-17,948
-2% -$101K ﹤0.01% 2748
2013
Q4 		$5.81M Sell
1,046,193
-43,401
-4% -$187K ﹤0.01% 2713
2013
Q3 		$4.91M Buy
1,089,594
+70,971
+7% +$318K ﹤0.01% 2742
2013
Q2 		$4.34M Buy
+1,018,623
New +$5.12M ﹤0.01% 2773

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BlackRock Institutional Trust's SGYP Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 12% in Q4 2016, buying an estimated $2.8M and bringing the position to 5,026,056 shares worth $30.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

BlackRock Institutional Trust first reported a position in SGYP in Q2 2013 and has held it in 15 quarters since. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • BlackRock Institutional Trust held 5,026,056 shares of Synergy Pharmaceuticals, Inc Common Stock worth $30.6M as of Q4 2016.
  • BlackRock Institutional Trust bought 535,118 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $2.8M.
  • Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1654 holding.
  • BlackRock Institutional Trust first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and has held it in 15 quarters since.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.